Dermatology Doctors in Lake Charles, LA Accepting Medicare

8 Dermatology doctors found. Showing 1 - 8

Dr. Michael Eddie Cormier, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee St, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

Lee Martin Miller, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee St, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

Dr. Shondra L. Smith, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3635 Nelson Road, Lake Charles, LA 70605 Phone: 337-477-0011    Fax: 337-477-0010

Dr. Brian Paul Ford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee St, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

Dr. Jenna Roach, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee Ln, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

Dr. Kevin A Guidry, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee St, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

Mrs. Maureen Olivier, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4150 Nelson Rd, Building E Suite 1, Lake Charles, LA 70605 Phone: 337-474-1386    Fax: 337-474-2845

Kerri Davis-fontenot, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2000 Tybee Ln, Lake Charles, LA 70605 Phone: 337-433-7272    Fax: 337-433-0730

News Archive

Amputees participate in UT Southwestern's neural interfacing study

Michael "Shawn" Findley, a 44-year-old amputee with a wiring harness emerging from his upper left arm, is working with a UT Southwestern team to help change the way robotic hand biofeedback occurs. Ultimately, he hopes this research may lead to the closest thing to feeling in the hands of every amputee.

Capsule endoscopy could identify presence of "occult" blood at very low levels

A tiny capsule that can carry out a chemical analysis of the contents of one's stomach could identify the presence of so-called "occult" blood at very low levels. The data is automatically broadcast to an external monitoring device for detection of early stage stomach cancer by one's physician. Details of the invention and initial trials are described in a forthcoming issue of the International Journal of Biomedical Engineering and Technology.

Durata commences dalbavancin Phase 3 study in acute bacterial skin and skin structure infections

Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).

2010 International Conference on Emerging Infectious Diseases at Atlanta, Georgia

Journalists are invited to attend and cover the 2010 International Conference on Emerging Infectious Diseases (ICEID), to be held July 11-14, 2010, at the Hyatt Regency, Atlanta, Georgia. The meeting is being organized by the Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories and the World Health Organization.

Read more Medical News

› Verified 5 days ago